Integrated network pharmacology and cellular assay reveal the biological mechanisms of Limonium sinense (Girard) Kuntze against Breast cancer
-
Published:2023-11-13
Issue:1
Volume:23
Page:
-
ISSN:2662-7671
-
Container-title:BMC Complementary Medicine and Therapies
-
language:en
-
Short-container-title:BMC Complement Med Ther
Author:
Zhao Hualong,Wang Siyuan,Williamson Philip T.F.,Ewing Rob M.,Tang Xinhui,Wang Jialian,Wang Yihua
Abstract
Abstract
Background
Limonium Sinense (Girard) Kuntze (L. sinense) has been widely used for the treatment of anaemia, bleeding, cancer, and other disorders in Chinese folk medicine. The aim of this study is to predict the therapeutic effects of L. sinense and investigate the potential mechanisms using integrated network pharmacology methods and in vitro cellular experiments.
Methods
The active ingredients of L. sinense were collected from published literature, and the potential targets related to L. sinense were obtained from public databases. Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) and DisGeNET enrichment analyses were performed to explore the underlying mechanisms. Molecular docking, cellular experiments, RNA-sequencing (RNA-seq) and Gene Expression Omnibus (GEO) datasets were employed to further evaluate the findings.
Results
A total of 15 active ingredients of L. sinense and their corresponding 389 targets were obtained. KEGG enrichment analysis revealed that the biological effects of L. sinense were primarily associated with “Pathways in cancer”. DisGeNET enrichment analysis highlighted the potential role of L. sinense in the treatment of breast cancer. Apigenin within L. sinense showed promising potential against cancer. Cellular experiments demonstrated that the L. sinense ethanol extract (LSE) exhibited a significant growth inhibitory effect on multiple breast cancer cell lines in both 2D and 3D cultures. RNA-seq analysis revealed a potential impact of LSE on breast cancer. Additionally, analysis of GEO datasets verified the significant enrichment of breast cancer and several cancer-related pathways upon treatment with Apigenin in human breast cancer cells.
Conclusion
This study predicts the biological activities of L. sinense and demonstrates the inhibitory effect of LSE on breast cancer cells, highlighting the potential application of L. sinense in cancer treatment.
Funder
Medical Research Council
Academy of Medical Sciences/the Wellcome Trust Springboard Award
Publisher
Springer Science and Business Media LLC
Subject
Complementary and alternative medicine
Reference60 articles.
1. Dong B. Research on the conservation of Limonium sinense in the coast of Jiangsu. Chin Wild Plant Res. 2005;24(06):28–30.
2. Chaung SS, et al. The hepatoprotective effects of Limonium sinense against carbon tetrachloride and beta-D-galactosamine intoxication in rats. Phytother Res. 2003;17(7):784–91.
3. Wu ZYPHR. Flora of China, ed. Z.Y.P.H.R. Wu. Vol. 15. 1996: Science Press (Beijing) & Missouri Botanical Garden Press (St. Louis).
4. Li H. Plumbaginaceae Flora of Taiwan. 1998;4:79–82.
5. Editorial Committee of Chinese Herbal, the State Administration of Traditional Chinese Medicine. Chinese Herbal. Vol XVI. Shanghai: Shanghai Science and Technology Publishers; 1999. p. 130.